Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
EBIT MarginEBITDA MarginEBT MarginFCF MarginInterest Coverage RatioNet MarginOperating MarginReturn on SalesTimes Interest Earned

Solid Biosciences (SLDB) Assets Average (2018 - 2024)

Solid Biosciences' Assets Average history spans 7 years, with the latest figure at $221.4 million for Q3 2024.

  • For Q3 2024, Assets Average rose 13.7% year-over-year to $221.4 million; the TTM value through Sep 2024 reached $221.4 million, up 13.7%, while the annual FY2023 figure was $212.6 million, 13.69% down from the prior year.
  • Assets Average for Q3 2024 was $221.4 million at Solid Biosciences, down from $239.8 million in the prior quarter.
  • Across five years, Assets Average topped out at $275.6 million in Q2 2021 and bottomed at $49.2 million in Q3 2020.
  • The 5-year median for Assets Average is $217.2 million (2023), against an average of $192.5 million.
  • The largest annual shift saw Assets Average crashed 56.66% in 2020 before it surged 422.78% in 2021.
  • A 5-year view of Assets Average shows it stood at $105.8 million in 2020, then surged by 127.4% to $240.7 million in 2021, then decreased by 7.61% to $222.4 million in 2022, then dropped by 21.37% to $174.8 million in 2023, then rose by 26.64% to $221.4 million in 2024.
  • Per Business Quant, the three most recent readings for SLDB's Assets Average are $221.4 million (Q3 2024), $239.8 million (Q2 2024), and $206.8 million (Q1 2024).